Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s):  MEDXF

Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:MDP)

Medexus Announces Strong Fiscal Q2 2025 Results

Newsfile 9 days ago

Medexus Schedules Second Fiscal Quarter 2025 Conference Call

Newsfile October 29, 2024

Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors

Newsfile September 19, 2024

FDA extends review period for Medexus' treosulfan to 2025

Jocelyn Aspa September 16, 2024

Medexus Provides Update on Treosulfan NDA Review Process and Extended PDUFA Goal Date

Newsfile September 16, 2024

Medexus Announces Strong Fiscal Q1 2025 Results

Newsfile August 7, 2024

Medexus Schedules First Fiscal Quarter 2025 Conference Call

Newsfile July 30, 2024

Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024

Newsfile June 25, 2024

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call

Newsfile June 18, 2024
View More News ››

Opinion & Analysis (TSX:MDP)

VIDEO: Focused on Children's Medicine in an Underserved Market

BTV-Business Television June 8, 2016

Pediapharm (V.PDP) is a very attractive takeover candidate, Stockhouse poster says

Stockhouse Editorial April 20, 2015
View More Opinion ››

Bullboard Posts (TSX:MDP)

$100M shelf prospectus filed

On sedar.
lscfa - 8 days ago

RE:RE:This article favor Treo over busulfan

Published on May 26, 2022, announced NDA resubmission on July 25, 2022, FDA rejected on September x https://onlinelibrary.wiley.com/doi...
Napcoo - May 21, 2024

RE:RE:RE:This article favor Treo over busulfan

On treosulfan, we are pleased to report that the data collection phase of medac's effort to respond to the FDA's information...
Napcoo - May 21, 2024

RE:RE:This article favor Treo over busulfan

An NDA includes all animal and human data and analyses of the data, as well as information about how the drug behaves in the body and how...
Napcoo - May 21, 2024

RE:This article favor Treo over busulfan

The second published by nature favor Treo https://www.nature.com/articles/s41409-024-02269-4
Napcoo - May 21, 2024

This article favor Treo over busulfan

https://www.nature.com/articles/s41409-023-02135-9
Napcoo - May 21, 2024
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »